Theravance Biopharma Gross Margin Growth & History (TBPH)

Theravance Biopharma's gross margin was 60.81% for fiscal 2017.

View full Theravance Biopharma company overview

Theravance Biopharma annual gross margin history

Theravance Biopharma annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20172017-12-3160.81%−33.24 pp
20162016-12-3194.05%+5.11 pp
20152015-12-3188.95%+23.66 pp
20142014-12-3165.28%−34.72 pp
20132013-12-31100.00%0.00 pp
20122012-12-31100.00%

Theravance Biopharma gross margin trends

Over the last five fiscal years, Theravance Biopharma's gross margin decreased from 100.00% to 60.81%, a change of −39.19 percentage points. The latest reported quarter, Q4 2017, shows 30.99%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Theravance Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about TBPH yet. Start the conversation.

Write the first post